Everything Brooklyn Needs to Know About Endoscopic Bariatric Therapy: 5 Key Points
Have you ever wondered if there’s a less invasive way to achieve meaningful weight loss without traditional surgery? For many people in Brooklyn, New York, endoscopic bariatric therapy (EBT) is becoming an increasingly popular solution. This approach offers effective, FDA-approved options that help patients lose weight safely while avoiding many risks associated with surgical procedures or pharmacological options. To help you understand this breakthrough better, here are five key points every Brooklyn resident should know about endoscopic bariatric therapy.
What Is Endoscopic Bariatric Therapy?
Endoscopic bariatric therapy is a minimally invasive weight loss treatment performed through the mouth using an endoscope—a flexible tube with a camera. Unlike traditional bariatric surgeries, EBT does not involve external incisions or significant recovery time. Instead, therapies like endoscopic sleeve gastroplasty (ESG) and gastric balloons reduce stomach size or volume internally, helping patients feel fuller faster and eat less.
FDA-Approved EBTs Offer Actual Results
Recent studies, including a comprehensive meta-analysis published in Gastrointestinal Endoscopy, confirm that all FDA-approved endoscopic bariatric therapies significantly outperform diet and lifestyle changes alone. Specifically, procedures like ESG and the Spatz3 adjustable gastric balloon have shown the most promising results for sustained weight loss at 12 months post-treatment. These options give Brooklyn patients powerful tools to support long-term success without surgery.
Customization and Adjustability Matter
One of the standout features of the Spatz3 adjustable gastric balloon is its customization capability. Unlike other balloons that stay fixed in size, the Spatz3 allows physicians to adjust the volume after placement. This flexibility lets doctors tailor treatment based on each patient’s progress and tolerance, optimizing weight loss outcomes while minimizing discomfort. This adaptability makes it a leading choice among non-surgical weight loss therapies in Brooklyn.
EBTs Provide a Safer Alternative to Surgery
While effective, traditional bariatric surgeries such as gastric bypass or sleeve gastrectomy come with risks, including longer recovery periods and potential complications. Endoscopic bariatric therapies reduce these risks by avoiding incisions and shortening downtime. Patients often return to normal activities sooner, making EBT an appealing option for those hesitant about surgery but seeking serious weight loss.
Continued Research Is Refining Patient Care
Though EBTs have shown impressive results, ongoing research emphasizes the importance of individualized patient selection and direct comparative studies. The goal is to help Brooklyn patients and their doctors choose the best therapy based on health history, weight loss goals, and lifestyle. This growing body of evidence promises to enhance treatment protocols and optimize outcomes.
Endoscopic bariatric therapy offers a promising path for Brooklyn residents aiming to lose weight safely and effectively without undergoing major surgery. With options like endoscopic sleeve gastroplasty and the adjustable Spatz3 gastric balloon, patients can benefit from minimally invasive procedures that promote lasting weight loss and improved quality of life.
If you have been considering weight loss solutions but want to avoid the risks and downtime associated with surgery, learning more about endoscopic bariatric therapy could be the next step.
Ready to explore effective, less invasive weight loss solutions? Schedule a consultation with Dr. Alexander Shapsis and our experienced Brooklyn, NY, team to discuss endoscopic bariatric therapy and take control of your health. Call EndoSlim Clinic of Atlantic Gastroenterology at 718 521-2840 to begin your journey toward a healthier you. Visit one of our offices located at Court Street, Bay Parkway, and Ocean Parkway. We also have an office at 12462 W Atlantic Blvd, Coral Springs, FL, 33071.
Share this Article
Back to Home Page